BRENDA O'SHEA: Open Payments
NPI 1538506522 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 25 payments from 10 companies in 2025. Trend: 2023 $408 · 2024 $333 · 2025 $536
Food & beverage: $521Education: $15
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $136 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Supernus Pharmaceuticals, Inc. | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Corium, LLC | 2 | $44 |
| Lundbeck LLC | 2 | $40 |
| Alkermes, Inc. | 2 | $33 |
| Almatica Pharma LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: ABILIFY ASIMTUFII, COBENFY, FANAPT, Qelbree, INVEGA SUSTENNA, Azstarys, ABILIFY MAINTENA, REXULTI.
Industry payments across IN — which companies pay providers there.
